Fake Mounjaro Scam: Unapproved 'Toneup' Tirzepatide Shots Sold via IndiaMART Written By Susmita Roy29 April 2026 4:15 PM ISTNew Delhi: The case of counterfeit Mounjaro injections being produced from a Sector 62 flat reveals a deeply troubling lapse in drug regulation and...
Tirzepatide Effective for Weight Reduction Among Patients on Weight-Inducing Medications, Also: JAMA Written By Medha Baranwal28 April 2026 9:00 PM ISTUSA: An analysis published in JAMA Network Open has revealed that tirzepatide produced significant weight loss in adults who were also taking...
Common obesity medications lead to higher muscle loss than other weight loss interventions, review finds Written By Dr. Kamal Kant Kohli26 April 2026 8:30 PM ISTA systematic review of clinical trials found that adults treated with incretin-based obesity medications, like semaglutide and tirzepatide, not only...
Typo Errors, Colour Mismatch Lead to Bust of Fake Mounjaro in Gurugram Written By sheeba farhat24 April 2026 10:45 AM ISTGurugram: Colour dissimilarity to typographical errors, conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs...
Gurugram Bust: Rs 70 Lakh Counterfeit Eli Lilly Mounjaro Recovered, 2 Arrested Written By Parthika Patel20 April 2026 7:30 PM ISTNew Delhi: In a major enforcement action, two individuals were arrested in Gurugram after the drugs control department seized a consignment of...
SURMOUNT-5 Trial: Tirzepatide vs Semaglutide in Obesity Management Written By MDTV Bureau20 April 2026 11:47 AM ISTThe SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or overweight with at least one...
GLP-1 Agonists Improve Outcomes in Psoriatic Arthritis with Obesity: Study Written By Medha Baranwal15 April 2026 8:30 PM ISTUSA: A phase III randomized trial showed that adding a GLP-1 agonist to standard psoriasis treatment significantly improved outcomes in patients with...
Tirzepatide Shows Superior Glycemic Control in Early Type 2 Diabetes, suggests research Written By Dr Riya Dave7 April 2026 9:00 AM ISTResearchers have found in a new study that Tirzepatide is more effective than conventional care for improving glycemic control and overall metabolic...
Tirzepatide Lowers Cardiovascular and Kidney Events vs Dulaglutide in High-Risk Diabetes: Study Written By Dr Riya Dave6 April 2026 8:00 AM ISTIn a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with...
Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Written By Deeksha Bhandari21 March 2026 9:00 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
Stopping GLP-1 drugs can quickly erase cardiovascular benefits, suggests study Written By Dr. Kamal Kant Kohli19 March 2026 10:15 PM ISTFollowing a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight...
GLP-1 medications get at the heart of addiction: study Written By Dr. Kamal Kant Kohli10 March 2026 9:00 PM ISTResearchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and...
